Jennifer H Tang1, Rosalie C Dominik2, Matthew L Zerden3, Sarah B Verbiest3, Seth C Brody4, Gretchen S Stuart3. 1. Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC 27523, USA. Electronic address: jennifer_tang@med.unc.edu. 2. Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27523, USA. 3. Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC 27523, USA. 4. Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC 27523, USA; Department of Obstetrics and Gynecology, WakeMed Health and Hospitals, Raleigh, NC, USA.
Abstract
OBJECTIVES: Short interpregnancy intervals are associated with adverse perinatal outcomes. Increased postpartum use of long-acting reversible contraception (LARC) could reduce short interpregnancy intervals. Therefore, the primary objective of our study was to evaluate if a postpartum educational script about LARC (LARC script) could increase postpartum LARC utilization at the 6-week postpartum visit. STUDY DESIGN: We completed a randomized controlled trial (1:1) of 800 postpartum women in Raleigh, North Carolina. Women were recruited from the postpartum unit and randomized toreceive (intervention) or not receive (control) the LARC script prior to hospital discharge. We conducted follow-up phone interviews to assess LARC use after their 6-week postpartum visit. We used Pearson's chi-squared test to compare LARC use between arms. RESULTS:Between May 2011 and January 2012, 400 women were randomized to each arm. Three hundred sixty-nine women (92.3%) in each arm were successfully contacted after their 6-week postpartum visit. LARC use was reported by 17.6% and 13.3% of women in the intervention and control arms, respectively (p=.103). CONCLUSIONS: The LARC script did not increase LARC utilization at the 6-week postpartum visit. Future studies should evaluate interventions that address both educational and systematic barriers to postpartum LARC uptake. IMPLICATIONS: Use of a postpartum educational script focused on the intrauterine device and contraceptive implant did not increase their utilization after the 6-week postpartum visit. Future studies should evaluate interventions that address both educational and systematic barriers to postpartum contraceptive uptake.
RCT Entities:
OBJECTIVES: Short interpregnancy intervals are associated with adverse perinatal outcomes. Increased postpartum use of long-acting reversible contraception (LARC) could reduce short interpregnancy intervals. Therefore, the primary objective of our study was to evaluate if a postpartum educational script about LARC (LARC script) could increase postpartum LARC utilization at the 6-week postpartum visit. STUDY DESIGN: We completed a randomized controlled trial (1:1) of 800 postpartum women in Raleigh, North Carolina. Women were recruited from the postpartum unit and randomized to receive (intervention) or not receive (control) the LARC script prior to hospital discharge. We conducted follow-up phone interviews to assess LARC use after their 6-week postpartum visit. We used Pearson's chi-squared test to compare LARC use between arms. RESULTS: Between May 2011 and January 2012, 400 women were randomized to each arm. Three hundred sixty-nine women (92.3%) in each arm were successfully contacted after their 6-week postpartum visit. LARC use was reported by 17.6% and 13.3% of women in the intervention and control arms, respectively (p=.103). CONCLUSIONS: The LARC script did not increase LARC utilization at the 6-week postpartum visit. Future studies should evaluate interventions that address both educational and systematic barriers to postpartum LARC uptake. IMPLICATIONS: Use of a postpartum educational script focused on the intrauterine device and contraceptive implant did not increase their utilization after the 6-week postpartum visit. Future studies should evaluate interventions that address both educational and systematic barriers to postpartum contraceptive uptake.
Authors: Lydia Furman; Shannon Pettit; Monique S Balthazar; Khalilah Williams; Mary Ann O'Riordan Journal: Eur J Contracept Reprod Health Care Date: 2020-12-09 Impact factor: 1.752
Authors: William C Livingood; Katryne Lukens Bull; Staci Biegner; Andrew M Kaunitz; LaRonda Howard; Vanessa Jefferson; Pia Julia Geisselmaier; Isabelle Michel; Lori Bilello Journal: F S Rep Date: 2022-02-23
Authors: Jennifer H Tang; Dawn M Kopp; Gretchen S Stuart; Michele O'Shea; Christopher C Stanley; Mina C Hosseinipour; William C Miller; Mwawi Mwale; Stephen Kaliti; Phylos Bonongwe; Nora E Rosenberg Journal: Contracept Reprod Med Date: 2016-08-10